Treatment approaches of gastrointestinal dysfunction in Parkinson's disease, therapeutical options and future perspectives

被引:15
|
作者
Woitalla, D. [1 ]
Goetze, O. [2 ]
机构
[1] Ruhr Univ Bochum, Dept Neurol, St Josef Hosp, D-44791 Bochum, Germany
[2] Univ Zurich Hosp, Div Gastroenterol & Hepatol, Zurich, Switzerland
关键词
Gastrointestinal dysfunction; Treatment options; Enteric nervous system; Gastroparesis; Parkinson's disease; ENTERIC NERVOUS-SYSTEM; PLACEBO-CONTROLLED TRIAL; FUNCTIONAL DYSPEPSIA; LEWY BODIES; RESPONSE FLUCTUATIONS; CHRONIC CONSTIPATION; HEALTHY-VOLUNTEERS; NONMOTOR SYMPTOMS; GASTRIC-MOTILITY; 5-HT4; AGONIST;
D O I
10.1016/j.jns.2011.06.050
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Gastrointestinal (GI) dysfunction is a common but underestimated feature in Parkinson's disease (PD). Out of the multimodal spectrum of treatment options, there currently are only a few pharmacological treatments available to improve gastrointestinal motility and symptoms. Because enteric nervous function is mainly regulated by transmitters different from those involved in the brain, dopamine replacement is not a treatment option in PD patients. This article focuses on the known regulative mechanism of Cl function and presents known and upcoming treatment options for GI dysfunction in PD. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:152 / 158
页数:7
相关论文
共 50 条
  • [21] Hormetic approaches to the treatment of Parkinson's disease: Perspectives and possibilities
    Calabrese, Vittorio
    Santoro, Aurelia
    Salinaro, Angela Trovato
    Modafferi, Sergio
    Scuto, Maria
    Albouchi, Ferdaous
    Monti, Daniela
    Giordano, James
    Zappia, Mario
    Franceschi, Claudio
    Calabrese, Edward J.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2018, 96 (10) : 1641 - 1662
  • [22] Future therapeutic options in Parkinson's!disease
    Wuellner, U.
    Buhmann, C.
    Hilker, R.
    Hummel, S.
    Korchounov, A.
    Mueller, T.
    Paulus, W.
    Schwartz, A.
    AKTUELLE NEUROLOGIE, 2007, 34 : S18 - S20
  • [23] Gastrointestinal dysfunction in idiopathic Parkinson's disease
    Del Tredici, K.
    Jost, W. H.
    NERVENARZT, 2012, 83 (10): : 1282 - +
  • [24] The Gastrointestinal Dysfunction Scale for Parkinson's Disease
    Camacho, Marta
    Greenland, Julia C.
    Williams-Gray, Caroline H.
    MOVEMENT DISORDERS, 2021, 36 (10) : 2358 - 2366
  • [25] Treatment options for Parkinson's disease
    Tintner, R
    Jankovic, J
    CURRENT OPINION IN NEUROLOGY, 2002, 15 (04) : 467 - 476
  • [26] Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson's Disease
    Prasuhn, Jannik
    Brueggemann, Norbert
    GENES, 2021, 12 (11)
  • [27] Gastrointestinal Dysfunction in Parkinson's Disease: Neuro-Gastroenterology Perspectives on a Multifaceted Problem
    Tan, Ai Huey
    Chuah, Kee Huat
    Beh, Yuan Ye
    Schee, Jie Ping
    Mahadeva, Sanjiv
    Lim, Shen-Yang
    JOURNAL OF MOVEMENT DISORDERS, 2023, 16 (02) : 138 - 151
  • [28] COMT inhibition in the treatment of Parkinson's disease: Neuroprotection and future perspectives
    Kostic, VS
    FRONTIERS IN CLINICAL NEUROSCIENCE: NEURODEGENERATION AND NEUROPROTECTION: A SYMPOSIUM IN ABEL LAJTHA'S HONOUR, 2004, 541 : 75 - 90
  • [29] The Gastrointestinal Dysfunction Scale - Parkinson's Disease (GIDS-PD): a new tool to assess gastrointestinal dysfunction in Parkinson's Disease
    Camacho, M.
    Greenland, J.
    Williams-Gray, C.
    MOVEMENT DISORDERS, 2021, 36 : S516 - S516
  • [30] Pathological correlates of gastrointestinal dysfunction in Parkinson's disease
    Cersosimo, Maria G.
    Benarroch, Eduardo E.
    NEUROBIOLOGY OF DISEASE, 2012, 46 (03) : 559 - 564